Ayman Al-Atta
Overview
Explore the profile of Ayman Al-Atta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
23
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Al-Atta A, Farag M, Jeyalan V, Gazzal Asswad A, Thompson A, Irvine T, et al.
Heart Lung Circ
. 2023 Nov;
32(12):1489-1499.
PMID: 37993343
Background: Transvalvular flow rate (TFR) represents a better reflection of transvalvular flow than the stroke volume index (SVi), and has recently emerged as a useful prognostic tool in patients undergoing...
2.
Al-Atta A, Spray L, Mohammed A, Shmeleva E, Spyridopoulos I
J Am Heart Assoc
. 2023 Sep;
12(18):e030473.
PMID: 37681545
Background Coronary microvascular dysfunction (CMD) predicts mortality after ST-elevation-myocardial infarction (STEMI). Arginine vasopressin (AVP) may be implicated, but data in humans are lacking, and no study has investigated the link...
3.
Ibrahem A, Farag M, Gue Y, Spinthakis N, Al-Atta A, Egred M
Heart Views
. 2023 Jun;
24(2):104-108.
PMID: 37305333
Methods: We performed a meta-analysis to evaluate the efficacy of CTO PCI. The study outcomes were the occurrence of all-cause mortality, myocardial infarction, repeat revascularization, stroke, or freedom from angina...
4.
Khan H, Rodwell P, Taha A, Goha A, Ahmed M, Thain A, et al.
J Cardiovasc Dev Dis
. 2023 Mar;
10(3).
PMID: 36975884
: We aimed to study the long-term association of LV mass index (LV) and myocardial fibrosis with ventricular arrhythmia (VA) in a population of patients with confirmed hypertrophic cardiomyopathy (HCM)...
5.
Farag M, Al-Atta A, Abdalazeem I, Salim T, Alkhalil M, Egred M
Catheter Cardiovasc Interv
. 2022 Jul;
100(3):360-366.
PMID: 35775815
Aims: There are limited data on outcomes of PCI in surgical turndown patientsespecially in those presenting with ACS. Methods And Results: A retrospective analysis of prospectively collected data of patients...
6.
Al-Atta A, Zaidan M, Abdalwahab A, Ghazal Asswad A, Egred M, Zaman A, et al.
Rev Cardiovasc Med
. 2022 Mar;
23(2):71.
PMID: 35229562
Patients with acute myocardial infarction (MI) complicated by cardiogenic shock (CS) have poor prognosis. Over the last two decades, there has been some improvement in mortality rates associated with CS....
7.
Abdalwahab A, Al-Atta A, Egred M, Alkhalil M, Zaman A
Rev Cardiovasc Med
. 2022 Jan;
23(1):33.
PMID: 35092225
The effects of coronary revascularization in patients with left ventricle systolic dysfunction (LVSD) are not well studied. The decision about revascularization and its timing remain challenging, not only related to...
8.
Al-Atta A, Kuzemczak M, Alkhalil M
Brain Circ
. 2021 Oct;
7(3):187-193.
PMID: 34667902
Background: Inflammation is increasingly recognized as a target to reduce residual cardiovascular risk. Colchicine is an anti-inflammatory drug that was associated with improved cardiovascular outcomes. However, its effect on stroke...
9.
Abdalwahab A, Al-Atta A, Zaman A, Alkhalil M
World J Cardiol
. 2021 Oct;
13(9):472-482.
PMID: 34621492
Statins have been shown to be effective in reducing cardiovascular events. Their magnitude of benefits has been proportionate to the reduction in low-density lipoprotein cholesterol (LDL-c). Intensive lipid-lowering therapies using...
10.
Jeyalan V, Al-Atta A, Das R, Edwards R, Zaman A, Alkhalil M
Cardiovasc Revasc Med
. 2021 May;
36:164-165.
PMID: 33966977
No abstract available.